| Advate |
125063 |
005 |
351(a) |
Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method |
For Injection |
Intravenous |
2000IU |
Single-Dose Vial |
2006/04/12
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Rotateq |
125122 |
001 |
351(a) |
Rotavirus Vaccine, Live, Oral, Pentavalent |
Suspension |
Oral |
2.2X10E6 IU |
Tube |
2006/02/03
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
|
N/A |
| Hepagam B |
125035 |
001 |
351(a) |
Hepatitis B Immune Globulin (Human) |
Injection |
Intramuscular |
>1560IU/5ML |
Single-Dose Vial |
2006/01/27
|
Kamada Ltd. |
Rx |
Licensed |
|
N/A |
| Hepagam B |
125035 |
002 |
351(a) |
Hepatitis B Immune Globulin (Human) |
Injection |
Intramuscular |
>312IU/ML |
Single-Dose Vial |
2006/01/27
|
Kamada Ltd. |
Rx |
Licensed |
|
N/A |
| Vivaglobin |
125115 |
001 |
351(a) |
Immune Globulin Subcutaneous (Human) |
For Injection |
Subcutaneous |
160MG/ML |
Vial |
2006/01/09
|
CSL Behring GmbH |
Disc |
Voluntarily Revoked |
|
|
| Elitek |
103946 |
002 |
351(a) |
rasburicase |
For Injection |
Intravenous |
7.5MG |
Single-Dose Vial |
2006/01/06
|
Sanofi-Aventis U.S. LLC |
Rx |
Licensed |
N/A |
N/A |
| Orencia |
125118 |
001 |
351(a) |
abatacept |
For Injection |
Intravenous |
250MG |
Single-Dose Vial |
2005/12/23
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
| Apidra |
021629 |
002 |
351(a) |
insulin glulisine |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Multi-Dose Cartridge |
2005/12/20
|
Sanofi-Aventis U.S. LLC |
Disc |
Licensed |
N/A |
N/A |
| Iplex |
021884 |
001 |
351(a) |
mecasermin rinfabate |
Injection |
Subcutaneous |
36MG/0.6ML (60MG/ML) |
Single-Dose Vial |
2005/12/12
|
Insmed Incorporated |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Hylenex recombinant |
021859 |
001 |
351(a) |
hyaluronidase human |
Injection |
Infiltration, Interstitial, Intramuscular, Intraocular, Peribulbar, Retrobulbar, Soft Tissue, Subcutaneous |
150UNITS/ML |
Single-Dose Vial |
2005/12/02
|
Halozyme Therapeutics, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Hydase |
021716 |
001 |
351(a) |
hyaluronidase |
Injection |
Subcutaneous |
150UNITS/ML |
Single-Dose Vial |
2005/10/25
|
Akorn, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Proquad |
125108 |
001 |
351(a) |
Measles, Mumps, Rubella and Varicella Virus Vaccine Live |
For Injection |
Subcutaneous |
0.5ML |
Single-Dose Vial |
2005/09/06
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
|
N/A |
| Fluarix, Fluarix Quadrivalent |
125127 |
001 |
351(a) |
Influenza Vaccine |
Injection |
Intramuscular |
45UG/.5ML |
Pre-Filled Syringe |
2005/08/31
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Increlex |
021839 |
001 |
351(a) |
mecasermin |
Injection |
Subcutaneous |
40MG/4ML (10MG/ML) |
Multi-Dose Vial |
2005/08/30
|
Eton Pharmaceuticals, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Follistim AQ |
021273 |
001 |
351(a) |
follitropin beta |
Injection |
Subcutaneous, Intramuscular |
75IU/0.5ML |
Single-Dose Vial |
2005/08/26
|
Organon USA Inc., a subsidiary of Merck & Co., Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Follistim AQ |
021273 |
002 |
351(a) |
follitropin beta |
Injection |
Subcutaneous, Intramuscular |
150IU/0.5ML |
Single-Dose Vial |
2005/08/26
|
Organon USA Inc., a subsidiary of Merck & Co., Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Autoplex, Feiba Nf, Feiba Vh |
101447 |
005 |
351(a) |
Anti-Inhibitor Coagulant Complex |
For Injection |
Intravenous |
2500U |
Single-Dose Vial |
2005/08/11
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Levemir |
021536 |
001 |
351(a) |
insulin detemir |
Injection |
Subcutaneous |
1,000UNITS/10ML (100UNITS/ML) |
Multi-Dose Vial |
2005/06/16
|
Novo Nordisk Inc. |
Disc |
Licensed |
N/A |
N/A |
| Levemir |
021536 |
002 |
351(a) |
insulin detemir |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
2005/06/16
|
Novo Nordisk Inc. |
Disc |
Licensed |
N/A |
N/A |
| Levemir |
021536 |
003 |
351(a) |
insulin detemir |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
2005/06/16
|
Novo Nordisk Inc. |
Disc |
Licensed |
N/A |
N/A |